AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer|HER-2 Positive Breast Cancer|ER Positive Breast Cancer
Interventions: DRUG: AUY922
Sponsor: Texas Tech University Health Sciences Center, El Paso